Burcon Announces Fiscal 2026 Second Quarter Results

Core Insights - Burcon NutraScience Corporation reported strong operational execution and growing commercial traction in the plant-based protein sector, reaffirming its revenue targets for 2025 and 2026 [2][3][6] Operational Highlights - Burcon has over 200 active customer projects, with many nearing completion, indicating a rapid scaling of demand and transition to recurring commercial sales [4] - The company successfully commercialized its technology for canola and fava protein production at its Galesburg facility [3] - Recent production runs have been allocated to innovative food and beverage companies, showcasing broad customer adoption [5] Financial Performance - For the fiscal second quarter ended September 30, 2025, Burcon generated revenues of $357,000, representing a 783% increase year-over-year [7] - The company reported a net loss of $7.1 million, compared to a loss of $4.2 million in the same period last year, driven by increased costs associated with production [9] - Cash used in operating activities increased to $4.6 million from $3.0 million in the prior year [9] Future Outlook - Burcon aims to achieve a revenue target of over $10 million for calendar 2026, supported by strong market validation and a diversified protein portfolio [6] - The company is focused on strengthening customer partnerships and scaling production to meet global demand [6] Financial Position - As of September 30, 2025, Burcon had $1.8 million in cash and a negative working capital of $8.2 million, primarily due to a senior secured loan from a related party [10] - The company has taken steps to improve its financial position, including obtaining a $0.7 million short-term loan and launching a convertible debenture offering for up to $4 million [10]